These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26327604)

  • 101. Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells.
    Momčilović O; Liu Q; Swistowski A; Russo-Tait T; Zhao Y; Rao MS; Zeng X
    Stem Cells Dev; 2014 Feb; 23(4):406-20. PubMed ID: 24074155
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Human pluripotent stem cells: an emerging model in developmental biology.
    Zhu Z; Huangfu D
    Development; 2013 Feb; 140(4):705-17. PubMed ID: 23362344
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Harnessing the potential of induced pluripotent stem cells for regenerative medicine.
    Wu SM; Hochedlinger K
    Nat Cell Biol; 2011 May; 13(5):497-505. PubMed ID: 21540845
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Somatic coding mutations in human induced pluripotent stem cells.
    Gore A; Li Z; Fung HL; Young JE; Agarwal S; Antosiewicz-Bourget J; Canto I; Giorgetti A; Israel MA; Kiskinis E; Lee JH; Loh YH; Manos PD; Montserrat N; Panopoulos AD; Ruiz S; Wilbert ML; Yu J; Kirkness EF; Izpisua Belmonte JC; Rossi DJ; Thomson JA; Eggan K; Daley GQ; Goldstein LS; Zhang K
    Nature; 2011 Mar; 471(7336):63-7. PubMed ID: 21368825
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Copy number variation and selection during reprogramming to pluripotency.
    Hussein SM; Batada NN; Vuoristo S; Ching RW; Autio R; Närvä E; Ng S; Sourour M; Hämäläinen R; Olsson C; Lundin K; Mikkola M; Trokovic R; Peitz M; Brüstle O; Bazett-Jones DP; Alitalo K; Lahesmaa R; Nagy A; Otonkoski T
    Nature; 2011 Mar; 471(7336):58-62. PubMed ID: 21368824
    [TBL] [Abstract][Full Text] [Related]  

  • 106. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.
    Nguyen HN; Byers B; Cord B; Shcheglovitov A; Byrne J; Gujar P; Kee K; Schüle B; Dolmetsch RE; Langston W; Palmer TD; Pera RR
    Cell Stem Cell; 2011 Mar; 8(3):267-80. PubMed ID: 21362567
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.
    Bock C; Kiskinis E; Verstappen G; Gu H; Boulting G; Smith ZD; Ziller M; Croft GF; Amoroso MW; Oakley DH; Gnirke A; Eggan K; Meissner A
    Cell; 2011 Feb; 144(3):439-52. PubMed ID: 21295703
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.
    Laurent LC; Ulitsky I; Slavin I; Tran H; Schork A; Morey R; Lynch C; Harness JV; Lee S; Barrero MJ; Ku S; Martynova M; Semechkin R; Galat V; Gottesfeld J; Izpisua Belmonte JC; Murry C; Keirstead HS; Park HS; Schmidt U; Laslett AL; Muller FJ; Nievergelt CM; Shamir R; Loring JF
    Cell Stem Cell; 2011 Jan; 8(1):106-18. PubMed ID: 21211785
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.
    Marchetto MC; Carromeu C; Acab A; Yu D; Yeo GW; Mu Y; Chen G; Gage FH; Muotri AR
    Cell; 2010 Nov; 143(4):527-39. PubMed ID: 21074045
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.
    Mayshar Y; Ben-David U; Lavon N; Biancotti JC; Yakir B; Clark AT; Plath K; Lowry WE; Benvenisty N
    Cell Stem Cell; 2010 Oct; 7(4):521-31. PubMed ID: 20887957
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Regularization Paths for Generalized Linear Models via Coordinate Descent.
    Friedman J; Hastie T; Tibshirani R
    J Stat Softw; 2010; 33(1):1-22. PubMed ID: 20808728
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.
    Hu BY; Weick JP; Yu J; Ma LX; Zhang XQ; Thomson JA; Zhang SC
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4335-40. PubMed ID: 20160098
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.
    Feng Q; Lu SJ; Klimanskaya I; Gomes I; Kim D; Chung Y; Honig GR; Kim KS; Lanza R
    Stem Cells; 2010 Apr; 28(4):704-12. PubMed ID: 20155819
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Takahashi K; Tanabe K; Ohnuki M; Narita M; Ichisaka T; Tomoda K; Yamanaka S
    Cell; 2007 Nov; 131(5):861-72. PubMed ID: 18035408
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Embryonic stem cell lines derived from human blastocysts.
    Thomson JA; Itskovitz-Eldor J; Shapiro SS; Waknitz MA; Swiergiel JJ; Marshall VS; Jones JM
    Science; 1998 Nov; 282(5391):1145-7. PubMed ID: 9804556
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
    Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
    Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Proteomics in the World of Induced Pluripotent Stem Cells.
    Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 6.